Wellington Management Group LLP Supernus Pharmaceuticals, Inc. Transaction History
Wellington Management Group LLP
- $557 Billion
- Q3 2024
A detailed history of Wellington Management Group LLP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 26,326 shares of SUPN stock, worth $936,415. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,326
Previous 40,676
35.28%
Holding current value
$936,415
Previous $1.09 Million
24.63%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SUPN
# of Institutions
282Shares Held
61.1MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$370 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$218 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$181 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$103 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$93.6 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.9B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...